Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA: Executive summary
Migrant health is receiving increasing attention in Europe and is a priority for ECDC. This report presents a summary of the main findings of an ECDC project to assess the burden of infectious diseases among migrants in the EU/EEA, based on available data for specific diseases: human immunodeficiency virus (HIV), tuberculosis (TB), hepatitis B, hepatitis C, gonorrhoea, syphilis, measles and rubella, malaria and Chagas disease.
A spatial modelling method for vector surveillance
14 Nov 2019 - Vector borne diseases are a specific group of infectious diseases that are a (re-)emerging threat to Europe. One important aspect of preparedness for vector borne diseases is the surveillance of the introduction, establishment and spread of the main disease vectors. ECDC regularly publishes updated vector distribution maps at the NUTS3 level. This document describes a methodology to estimate the vector distribution status for those NUTS3 units for which observations are not yet available . These estimates are produced with spatial modelling techniques, using the currently available distributions to calibrate the modelling process. This document provides an overview of gap analysis procedures, sets out the full methodology, and also provide s details of which methodological components were used with each output provided.
Health emergency preparedness for imported cases of high-consequence infectious diseases
22 Oct 2019 - To support countries in the European Union/European Economic Area (EU/EEA) in their review of preparedness system planning, ECDC launches an operational checklist for health emergency preparedness for imported cases of high consequence infectious diseases.
HIV and people who inject drugs - Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
9 Oct 2019 - This report summarises key issues related to HIV and people who inject drugs in Europe and Central Asia based on data provided by countries for reporting on the Dublin Declaration in 2018.